Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Olov Fagerström

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Addictive Behaviors|December 3, 2013
Tobacco harm reduction: the need for new products that can compete with cigarettesKarl Olov Fagerström, Kevin Bridgman
Addiction (Abingdon, England)|August 22, 2003
Should the European Union lift the ban on snus? Evidence from the Swedish experienceKarl Olov Fagerström, Elsy-Britt Schildt
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 8, 2003
Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a reviewKarl Olov Fagerström, John R Hughes
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 8, 2003
Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quittingKarl Olov Fagerström, John R Hughes, Peter W Callas
Respiration; International Review of Thoracic Diseases|April 19, 2013
Predictors of success for smoking cessation at the workplace: a longitudinal studyDaiana Stolz, Andreas Scherr, Bruno Seiffert, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 28, 2003
Development and validation of a self-rating scale for positive- and negative-reinforcement smoking: The Michigan Nicotine Reinforcement QuestionnaireOvide F Pomerleau, Karl-Olov Fagerström, Judith L Marks, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 9, 2013
Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trialSerena Tonstad, Eli Heggen, Hans Giljam, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Addictive Behaviors|December 3, 2013
Tobacco harm reduction: the need for new products that can compete with cigarettesKarl Olov Fagerström, Kevin Bridgman
Addiction (Abingdon, England)|August 22, 2003
Should the European Union lift the ban on snus? Evidence from the Swedish experienceKarl Olov Fagerström, Elsy-Britt Schildt
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 8, 2003
Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a reviewKarl Olov Fagerström, John R Hughes
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 8, 2003
Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quittingKarl Olov Fagerström, John R Hughes, Peter W Callas
Respiration; International Review of Thoracic Diseases|April 19, 2013
Predictors of success for smoking cessation at the workplace: a longitudinal studyDaiana Stolz, Andreas Scherr, Bruno Seiffert, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 28, 2003
Development and validation of a self-rating scale for positive- and negative-reinforcement smoking: The Michigan Nicotine Reinforcement QuestionnaireOvide F Pomerleau, Karl-Olov Fagerström, Judith L Marks, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 9, 2013
Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trialSerena Tonstad, Eli Heggen, Hans Giljam, et al.
Pageof 1